AI assistant
PFIZER INC — Director's Dealing 2008
Apr 8, 2008
29831_dirs_2008-04-07_80ab4477-feb5-467a-92bf-e2cd687bb5eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: ENCYSIVE PHARMACEUTICALS INC (ENCY)
CIK: 0000887023
Period of Report: 2008-04-01
Reporting Person: PFIZER INC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-04-01 | Common Stock | P | 166666 | $2.35 | Acquired | 61931961 | Indirect |
| 2008-04-02 | Common Stock | P | 914512 | $2.35 | Acquired | 62846473 | Indirect |
Footnotes
F1: This amendment is made solely to correct the original Form 4 filed on April 3, 2008 to (i) remove the 8,473,574 shares that
had been included in the amount of securities beneficially owned on April 1, 2008 and the 7,512,764 shares that had been
included in the amount of securities benefically owned on April 2, 2008 because such shares were subject to guaranteed
delivery procedures and (ii) correct the amount of securities acquired on each of April 1, 2008 and April 2, 2008.
F2: Shares are directly owned by Explorer Acquisition Corp., a wholly-owned subsidiary of Pfizer Inc.